on BOIRON (EPA:BOI)
Boiron finalizes the acquisition of Hivital Labs to strengthen its e-commerce
On November 16, 2026, Boiron Laboratories announced the complete acquisition of Hivital Labs, a Spanish company specializing in food supplements. Founded in 2018, Hivital Labs offers approximately 70 health and wellness products, distributed primarily online in Spain, Germany, Italy, and France. This transaction marks a strategic turning point for Boiron, aiming to expand its presence in the food supplement and e-commerce markets.
This integration aligns with Boiron's vision implemented since 2025 and allows them to capitalize on Hivital Labs' digital expertise. Pascal Houdayer, CEO of Boiron, emphasizes the complementarity of the two companies in a shared vision of integrative healthcare. Despite this acquisition, Hivital Labs retains its autonomy, its management team, and its brand, with Ferran Forcada at its helm. The unanimous approval of the Board of Directors and the support of employees validate this transaction, financed by available cash.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BOIRON news